Head-to-head · Cost-Efficiency Index
Alinwell vs ARSYNL Rx
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Alinwell
Readers who want to see the compounding certificates before they buy, and who will look past the advertised figure to the price that renews.
Visit AlinwellARSYNL Rx
Cost-first shoppers who want a needle-free tirzepatide hypospray option alongside standard compounded injections, from a veteran-founded telehealth brand.
Visit ARSYNL RxThe verdict
Alinwell takes it, leading the Cost-Efficiency Index 57 to 56. Alinwell markets compounded GLP-1s to women from $149 a month, but that figure is a first-month discount: the standing rates are $249 for semaglutide and $299 for tirzepatide, and neither appears until checkout. ARSYNL Rx still earns a C — Cost-first shoppers who want a needle-free tirzepatide hypospray option alongside standard compounded injections, from a veteran-founded telehealth brand.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Alinwell.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Alinwell | ARSYNL Rx |
|---|---|---|
| Cost-Efficiency Index | 57/100 | 56/100 |
| Semaglutide / mo | $249/mo month-to-month (charged every 30 days; the advertised $149 is the first month only) | $233/mo (starting dose, compounded) |
| Tirzepatide / mo | $299/mo month-to-month (charged every 30 days; the advertised $199 is the first month only) | $233/mo (starting dose, compounded) |
| Semaglutide / yr (modeled) | $2,988 | $2,796 |
| Tirzepatide / yr (modeled) | $3,588 | $2,796 |
| Coverage | All 50 states | Coverage not published |
| Oral / sublingual | Yes | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #316 | #320 |
Alinwell
57/100Where the value is
- Links a certificate of analysis for each GLP-1 from the treatment page itself, naming the compounding pharmacy, the strength and the testing laboratory
- The monthly figure includes physician review, care coaching, a dietitian visit and expedited shipping, with no separate consultation or dose-change fee
- Three- and six-month rates are shown side by side at checkout rather than being quoted only on request
The tradeoffs
- Every advertised price is an introductory one: "from $149/mo" and "from $199/mo" are labeled "$100 off first month" at checkout, with $249 and $299 struck through beside them
- The three-month plan costs more per month than the advertised monthly figure ($219 against $149), because the advertised figure was never a rate
ARSYNL Rx
56/100Where the value is
- Genuinely veteran-founded — the About page names founder Arron Glysch and recounts his own hair-loss experience while deployed overseas
- Offers a needle-free tirzepatide HypoSpray with six published dose protocols (10mg-60mg total/month)
- All three GLP-1 SKUs are stated to already include the consultation and shipping in the quoted price
The tradeoffs
- No compounding pharmacy is named on any product page checked
- No individual medical director or prescriber is named anywhere accessible — only 'U.S. board certified physicians' as a category
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.